TNDM

18.64

1.58% -0.30

Vorhandelsmarkt: 17.92 -0.72 -3.86%

Tandem Diabetes Care Inc (TNDM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TNDM? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$18.94

Offen:

$18.955

24-Stunden-Volumen:

1.24M

Relative Volume:

0.84

Marktkapitalisierung:

$1.49B

Einnahmen:

$796.00M

Nettoeinkommen (Verlust:

$-136.49M

KGV:

-8.9187

EPS:

-2.09

Netto-Cashflow:

$-64.24M

1W Leistung:

-7.81%

1M Leistung:

-5.95%

6M Leistung:

-48.25%

1J Leistung:

-53.74%

1-Tages-Spanne:

$18.57

$19.23

1-Wochen-Bereich:

$18.54

$21.18

52-Wochen-Spanne:

$15.75

$48.24

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Firmenname

Tandem Diabetes Care Inc

Sektor

Healthcare (1173)

Branche

Medical Devices (149)

Telefon

858-366-6900

Adresse

12400 HIGH BLUFF DRIVE, San Diego, CA

Mitarbeiter

2,650

Twitter

@tandemdiabetes

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

TNDM's Discussions on Twitter

Vergleichen Sie TNDM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNDM Tandem Diabetes Care Inc	18.64	1.49B	796.00M	-136.49M	-64.24M	-2.09
ABT Abbott Laboratories	136.01	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	107.41	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	395.63	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	87.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	78.21	44.46B	5.54B	4.18B	623.10M	7.00

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-16	Eingeleitet	Truist	Hold
2025-04-10	Eingeleitet	Mizuho	Neutral
2025-03-05	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-03-04	Herabstufung	Citigroup	Buy → Neutral
2025-03-03	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-02-28	Herabstufung	Bernstein	Outperform → Mkt Perform
2024-12-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-11-06	Eingeleitet	Bernstein	Outperform
2024-10-04	Eingeleitet	Goldman	Neutral
2024-10-02	Eingeleitet	RBC Capital Mkts	Outperform
2024-08-22	Eingeleitet	Morgan Stanley	Equal-Weight
2024-08-08	Eingeleitet	Canaccord Genuity	Buy
2024-05-30	Eingeleitet	Redburn Atlantic	Buy
2024-05-22	Hochstufung	Citigroup	Neutral → Buy
2024-04-29	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-04-25	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-03-26	Hochstufung	Stifel	Hold → Buy
2023-08-04	Herabstufung	Citigroup	Buy → Neutral
2023-05-05	Herabstufung	BofA Securities	Neutral → Underperform
2023-04-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-03-29	Eingeleitet	UBS	Neutral
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-15	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-08-09	Herabstufung	Wells Fargo	Overweight → Underweight
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2022-01-19	Hochstufung	Wells Fargo	Equal Weight → Overweight
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Underweight
2020-12-15	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-08-20	Eingeleitet	Wells Fargo	Overweight
2020-07-31	Hochstufung	Guggenheim	Neutral → Buy
2020-07-06	Hochstufung	Citigroup	Neutral → Buy
2020-06-18	Bestätigt	Raymond James	Outperform
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-03-23	Herabstufung	Guggenheim	Buy → Neutral
2020-03-05	Eingeleitet	Citigroup	Neutral
2020-02-06	Eingeleitet	Raymond James	Outperform
2020-02-04	Herabstufung	Robert W. Baird	Outperform → Neutral
2019-10-18	Eingeleitet	Guggenheim	Buy
2019-10-04	Hochstufung	UBS	Neutral → Buy
2019-05-17	Bestätigt	BofA/Merrill	Neutral
2019-05-13	Eingeleitet	SVB Leerink	Outperform
2019-03-08	Eingeleitet	BMO Capital Markets	Outperform
2019-03-05	Bestätigt	BofA/Merrill	Neutral
2019-02-27	Bestätigt	Lake Street	Buy
2018-11-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2018-09-26	Bestätigt	Dougherty & Company	Buy
2018-09-26	Bestätigt	Piper Jaffray	Overweight

Alle ansehen

Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten

Jun 18, 2025

Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - MSN

Jun 18, 2025

Jun 17, 2025

How To Trade (TNDM) - news.stocktradersdaily.com

Jun 17, 2025

Digital Diabetes Management Market 2025Growth in Apps, - openPR.com

Jun 17, 2025

Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities - FinancialContent

Jun 17, 2025

What Does Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Share Price Indicate? - Yahoo Finance

Jun 17, 2025

Tandem Diabetes Care’s SWOT analysis: stock faces growth hurdles amid market shifts - Investing.com Nigeria

Jun 17, 2025

Jun 16, 2025

TNDM: Truist Securities Initiates Coverage with Hold Rating | TN - GuruFocus

Jun 16, 2025

TNDM: Truist Securities Initiates Coverage with Hold Rating | TNDM Stock News - GuruFocus

Jun 16, 2025

10 Best Stocks to Buy For Beginners Now - Insider Monkey

Jun 16, 2025

Truist bullish on diabetes companies citing potential market growth - Seeking Alpha

Jun 16, 2025

Truist initiates Tandem Diabetes Care stock with hold rating By Investing.com - Investing.com Canada

Jun 16, 2025

Tandem Diabetes (TNDM) Receives Hold Rating from Truist | TNDM S - GuruFocus

Jun 16, 2025

Truist Initiates Tandem Diabetes Care at Hold With $24 Price Target - MarketScreener

Jun 16, 2025

Jun 11, 2025

Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st

Jun 11, 2025

Jun 10, 2025

Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive

Jun 10, 2025

Abbott to pair glucose-ketone sensor with Tandem's insulin pumps - Modern Healthcare

Jun 10, 2025

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor - MarketScreener

Jun 10, 2025

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued By Stocktwits - Investing.com India

Jun 10, 2025

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued - Asianet Newsable

Jun 10, 2025

Diabetes partnerships abound ahead of ADA - BioWorld MedTech

Jun 10, 2025

Tandem Diabetes at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Jun 10, 2025

Transcript : Tandem Diabetes Care, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025

Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus

Jun 10, 2025

Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha

Jun 10, 2025

Tandem Diabetes Care Announces Agreement With Abbott For Integration Of Automated Insulin Delivery Systems With Future Glucose-Ketone Sensor - marketscreener.com

Jun 10, 2025

Tandem Diabetes, Abbott to Merge Insulin Pump with Future Glucose-Ketone Sensor - Medical Product Outsourcing

Jun 10, 2025

Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus

Jun 10, 2025

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor | TNDM Stock News - GuruFocus

Jun 10, 2025

3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance

Jun 10, 2025

Jun 09, 2025

Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - MarketScreener

Jun 09, 2025

Tandem to pay Roche $36M in patent dispute settlement - MSN

Jun 09, 2025

Jun 05, 2025

Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround (NASDAQ:TNDM) - Seeking Alpha

Jun 05, 2025

Jun 04, 2025

(TNDM) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 04, 2025

Tandem Diabetes at Jefferies: Expanding Market Horizons By Investing.com - Investing.com Canada

Jun 04, 2025

How the Non-Invasive Drug Delivery Device Market Will Evolve - openPR.com

Jun 04, 2025

Do You Believe in the Long-Term Growth Potential of Tandem Diabetes Care (TNDM)? - Insider Monkey

Jun 04, 2025

Jun 03, 2025

Roche settles UPC dispute over insulin distribution technology - JUVE Patent

Jun 03, 2025

Jun 02, 2025

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga

Jun 02, 2025

May 31, 2025

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of “Hold” from Analysts - Defense World

May 31, 2025

May 30, 2025